tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniel Busby, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst Daniel Busby, carries an average stock price target met ratio of 25% that have a potential upside of 56.65% achieved within 73 days.
Daniel Busby’s has documented 16 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 10-Aug-2023.
Analyst best performing recommendations are on VRCA (VERRICA PHARMACEUTICALS).
The best stock recommendation documented was for VRCA (VERRICA PHARMACEUTICALS) at 5/25/2022. The price target of $4 was fulfilled within 79 days with a profit of $1.99 (99%) receiving and performance score of 12.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$14
3 months 1 days ago
(06-Nov-2024)
0/13 (0%)
$4.51 (47.52%)
Hold
$12
3 months 2 days ago
(05-Nov-2024)
3/12 (25%)
$10.55 (727.59%)
169
Buy
$2
$0.99 (98.02%)
$11
3 months 2 days ago
(05-Nov-2024)
1/8 (12.5%)
$1.14 (132.56%)
79
Buy
$10
$8.99 (890.10%)
$10
1 years 1 months 23 days ago
(15-Dec-2023)
0/2 (0%)
$3.91 (64.20%)
Buy
$14
$12.99 (1286.14%)
$4
1 years 6 months 13 days ago
(25-Jul-2023)
1/4 (25%)
$8.68 (163.16%)
79
What Year was the first public recommendation made by Daniel Busby?
